The Drug Update: Recent drug approvals, summer 2026 edition
Listen to this summary
This article reviews recent drug approvals by the US Food and Drug Administration in the latter half of 2025, focusing on medications relevant to primary care practitioners. It highlights new drugs such as brensocatib, elinzanetant, and zoliflodacin, as well as new indications for existing therapies like finerenone for heart failure and cyclobenzaprine for fibromyalgia. The authors aim to inform healthcare providers about these updates to enhance patient care.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from The Nurse practitioner
View all →Aug 27, 2026 · The Nurse practitioner
Current knowledge and use of pharmacogenomics among NPs: An integrative review
Aug 25, 2026 · The Nurse practitioner
Assessing comorbidities and predicting risk: A primer for APRNs
Aug 25, 2026 · The Nurse practitioner
Metabolic dysfunction-associated steatotic liver disease: A primer for primary care NPs
Aug 25, 2026 · The Nurse practitioner
An examination of how APRNs perceive sharing clinical notes with their patients: A follow-up
Aug 5, 2026 · The Nurse practitioner
An emphasis on professionalism for new NP students
Jul 31, 2026 · The Nurse practitioner
A novel adjunct for COPD: Could it be type II inflammation?
More in Nurse Practitioner
View all →Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 23, 2026 · The American journal of psychiatry
Age-Associated Cognitive Deviations in Early-Onset Psychosis Patients and Their Siblings
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · JAMA
Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


